The MRE11 data are representative of such fragile balance: while the Cu pre-treatment leads to early MRE11 foci in MD cells (as observed in cancer syndromes), it also increases late MRE11 foci in WD cells as observed in aging syndromes (Table 2). Here, MRE11 is linked to Wilson disease.